A phase I/II study of CY and topotecan in patients with high-risk malignancies undergoing autologous hematopoietic cell transplantation: the St Jude long-term follow-up

DSpace Repository

A phase I/II study of CY and topotecan in patients with high-risk malignancies undergoing autologous hematopoietic cell transplantation: the St Jude long-term follow-up

Author: Kasow, K. A.; Stewart, C. F.; Barfield, R. C.; Wright, N. L.; Li, C.; Srivastava, D. K.; Leung, W.; Horwitz, E. M.; Bowman, L. C.; Handgretinger, R.; Hale, G. A.
Tübinger Autor(en):
Handgretinger, Rupert
Published in: Bone Marrow Transplantation (2012), Bd. 47, H. 11, S. 1448-1454
Verlagsangabe: Nature Publishing Group
Language: English
Full text: http://dx.doi.org/10.1038/bmt.2012.51
ISSN: 0268-3369
DDC Classifikation: 570 - Life sciences; biology
530 - Physics
610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)